ARMISTICE CAPITAL, LLC - 31 Mar 2025 SCHEDULE 13G Report for BICYCLE THERAPEUTICS PLC American Depositary Shares, each representing one ordinary share, nominal value 0.01 per share (BCYC)

Filing Manager
ARMISTICE CAPITAL, LLC
Reporting Manager
Armistice Capital, LLC
Security
BICYCLE THERAPEUTICS PLC American Depositary Shares, each representing one ordinary share, nominal value 0.01 per share
Symbol
BCYC
Shares outstanding
47,799,642 shares
Disclosed Ownership
2,672,000 shares
Ownership
5.6%
Form type
SCHEDULE 13G
Filing time
15 May 2025, 15:08:57 UTC
Date of event
31 Mar 2025
Next filing
18 Feb 2026
SEC
View on sec.gov

Quoteable Key Fact

"ARMISTICE CAPITAL, LLC disclosed 5.6% ownership in BICYCLE THERAPEUTICS PLC American Depositary Shares, each representing one ordinary share, nominal value 0.01 per share (BCYC) on 31 Mar 2025."

Quick Takeaways

  • ARMISTICE CAPITAL, LLC filed SCHEDULE 13G for BICYCLE THERAPEUTICS PLC American Depositary Shares, each representing one ordinary share, nominal value 0.01 per share (BCYC).
  • Disclosed ownership: 5.6%.
  • Date of event: 31 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 15 May 2025, 15:08.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Armistice Capital, LLC 5.6% 2,672,000 0 2,672,000 /s/ Steven Boyd Steven Boyd - Managing Member
Steven Boyd 5.6% 2,672,000 0 2,672,000 /s/ Steven Boyd Steven Boyd